AstraZeneca Pharmaceuticals LP
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of[...]
Regeneron Pharmaceuticals Inc.
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in[...]
04/26/2024 | Press release | Distributed by Public on 04/26/2024 07:13
Please select the service you want to use:
Smartlinks | technotrans SE | Company News | Shareholders | Shareholder Meeting | Securities Issuers | Industrial Equipment and Components Manufacturers | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Berlin Stock Exchange | Dusseldorf Stock Exchange | Hamburg Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | BX Swiss | Tradegate Exchange | XETRA | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | SIGMA X MTF | Euronext Block MTF | Turquoise
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact